Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Heron Therapeutics (HRTX) over the last 5 years, with Q3 2025 value amounting to 0.43.

  • Heron Therapeutics' Debt Ratio rose 28393.34% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 28393.34%. This contributed to the annual value of 0.11 for FY2024, which is 156.29% down from last year.
  • Latest data reveals that Heron Therapeutics reported Debt Ratio of 0.43 as of Q3 2025, which was up 28393.34% from 0.11 recorded in Q1 2025.
  • Heron Therapeutics' 5-year Debt Ratio high stood at 0.43 for Q3 2025, and its period low was 0.1 during Q3 2023.
  • Moreover, its 3-year median value for Debt Ratio was 0.11 (2023), whereas its average is 0.15.
  • Examining YoY changes over the last 5 years, Heron Therapeutics' Debt Ratio showed a top increase of 28393.34% in 2025 and a maximum decrease of 468.2% in 2025.
  • Quarter analysis of 3 years shows Heron Therapeutics' Debt Ratio stood at 0.11 in 2023, then decreased by 1.56% to 0.11 in 2024, then surged by 302.24% to 0.43 in 2025.
  • Its Debt Ratio was 0.43 in Q3 2025, compared to 0.11 in Q1 2025 and 0.11 in Q4 2024.